Orthofix Medical Inc. Deferred State and Local Income Tax Expense (Benefit)
Orthofix Medical Inc. (OFIX) reported Deferred State and Local Income Tax Expense (Benefit) of $134.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-02-24
- Orthofix Medical Inc. deferred state and local income tax expense (benefit) for fiscal 2025 was $134.00K, a 38.25% decline from fiscal 2024.
- Orthofix Medical Inc. deferred state and local income tax expense (benefit) for fiscal 2024 was $217.00K, a 42.76% increase from fiscal 2023.
- Orthofix Medical Inc. deferred state and local income tax expense (benefit) for fiscal 2023 was $152.00K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $134.00K 10-K · filed 2026-02-24 |
| 2024-12-31 | $217.00K 10-K · filed 2026-02-24 |
| 2023-12-31 | $152.00K 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |